About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
GRTX
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Galera Therapeutics GAAP EPS of -$0.33
- Galera plunges after citing risks to business continuity
- Galera Therapeutics GAAP EPS of -$0.48
- Galera cut to Underperform at BofA after FDA snub for lead asset
- FDA rejects Galera mouth sores treatment; stock -83% after hours
- Galera wins FDA’s orphan drug status for pancreatic cancer therapy
- Galera Therapeutics GAAP EPS of -$0.50 misses by $0.09
- Galera Therapeutics GAAP EPS of -$0.58 misses by $0.06
- Galera raised to Buy at BofA; says FDA priority review “lifts key overhang”
- Galera Therapeutics down after announcing ~$30M registered direct offering
- Galera rises as FDA grants priority review for lead asset
- Galera Therapeutics GAAP EPS of -$0.60 misses by $0.13
- Galera Therapeutics appoints chief medical officer
- Galera Therapeutics GAAP EPS of -$0.54
- Galera down ~8% after phase 1 data for non-small cell lung cancer combination treatment
- Galera Therapeutics GAAP EPS of -$0.58
- Galera plans to file for US approval of avasopasem by end of year
- Galera's avasopasem helps reduce severe esophagitis in cancer patients receiving chemoradiotherapy in trial
- Galera Therapeutics GAAP EPS of -$0.64 beats by $0.10
- Galera Therapeutics up 3% as analyst upgrade continues to boost shares
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | 2.280 | 2.240 |
2.340
|
2.180
|
158.62K | 1.79% | ||||
| Mar 9 | 2.240 | 2.020 |
2.320
|
2.020
|
326.25K | 11.44% | ||||
| Mar 8 | 2.010 | 2.090 |
2.120
|
1.920
|
339.46K | -1.47% | ||||
| Mar 7 | 2.040 | 2.070 |
2.200
|
2.040
|
233.23K | -4.67% | ||||
| Mar 4 | 2.140 | 2.120 |
2.160
|
2.060
|
128.90K | 0% | ||||
| Mar 3 | 2.140 | 2.190 |
2.200
|
2.080
|
209.44K | -0.93% | ||||
| Mar 2 | 2.160 | 2.120 |
2.290
|
2.050
|
505.66K | 1.41% | ||||
| Mar 1 | 2.130 | 2.240 |
2.280
|
2.095
|
265.23K | -4.91% | ||||
| Feb 28 | 2.240 | 2.190 |
2.340
|
2.190
|
231.87K | -0.44% | ||||
| Feb 25 | 2.250 | 2.270 |
2.300
|
2.160
|
205.99K | 0.90% | ||||
| Feb 24 | 2.230 | 2.080 |
2.300
|
2.040
|
838.77K | -1.76% | ||||
| Feb 23 | 2.270 | 2.450 |
2.460
|
2.250
|
364.65K | -6.97% | ||||
| Feb 22 | 2.440 | 2.275 |
2.500
|
2.275
|
487.24K | 2.52% | ||||
| Feb 18 | 2.380 | 2.490 |
2.500
|
2.360
|
193.30K | -4.42% | ||||
| Feb 17 | 2.490 | 2.550 |
2.629
|
2.420
|
800.67K | -3.49% | ||||
| Feb 16 | 2.580 | 2.310 |
2.600
|
2.310
|
450.88K | 10.26% | ||||
| Feb 15 | 2.340 | 2.300 |
2.390
|
2.200
|
582.48K | 5.41% | ||||
| Feb 14 | 2.220 | 2.290 |
2.340
|
2.180
|
235.73K | -2.2% | ||||
| Feb 11 | 2.270 | 2.340 |
2.370
|
2.200
|
363.90K | -2.58% | ||||